Repligen Corporation to Present at Evercore Healthcare Conference
Repligen (NASDAQ:RGEN) will participate in the 8th Annual Evercore Healthcare Conference taking place Dec 2–4, 2025 in Coral Gables, Florida.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Repligen (NASDAQ:RGEN) will participate in the 8th Annual Evercore Healthcare Conference taking place Dec 2–4, 2025 in Coral Gables, Florida.
Jason Garland, Chief Financial Officer, will join an analyst-led discussion on Dec 3, 2025 at 1:20 p.m. ET. A live webcast will be available on Repligen’s Investor Relations website at www.repligen.com, with a limited-time replay following the event.
Details
News Market Reaction – RGEN
On Nov 26, the day this news came out, RGEN closed 0.34% below the previous close.
Data tracked by StockTitan Argus for the Nov 26 session.
Key Figures
- Conference dates
- December 2–4, 2025
- 8th Annual Evercore Healthcare Conference schedule
- Presentation time
- December 3, 1:20 p.m. ET
- CFO analyst-led discussion slot
Historical Context
-
Announcement of Evercore Healthcare Conference appearance with webcast access details.
-
Outlined five November 2025 investor conferences with executive participation.
-
Reported Q3 2025 growth with $189M revenue and raised 2025 guidance to $729M–$737M.
-
Set date and access details for Q3 2025 financial results call and webcast.
-
Announced three September 2025 healthcare conferences with CEO/CFO participation.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WALTHAM, Mass., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participate in the 8th Annual Evercore Healthcare Conference, being held December 2 -4 in Coral Gables, Florida. Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion on December 3rd at 1:20 p.m. ET.
A live webcast of the conference presentations will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.
About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the our company see our website at www.repligen.com, and follow us on LinkedIn.
Repligen Contact:
Jacob Johnson
VP, Investor Relations
781-419-0204
investors@repligen.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.